Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2005.207 | Analgesic Efficacy and Pharmacokinetic of Ropivacaine Continuous Wound Instillation Following Hepatic Resection | Dr. Chan K.C. Simon |
2005.197 | An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL_/CAELYX_ and YONDELIS | Prof. Yeo Winnie |
2005.196 | An Expanded Access Program of Tarceva (Erlotinib) in Patients with Advanced Stage IIIB/IV Non-Small Cell Lung Cancer | Prof. Mok S.K. Tony |
2005.192 | The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial | Dr. Wu Che Yuen Justin |
2005.189 | Randomized, Open-Label, Comparative Study To Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Na_ve Adults with Chronic Hepatitis B Infection | Dr. Leung Wai Yee Nancy |
2005.186 | A Prospective Randomized Comparison of A Novel Hemostatic Clip (Resolution Clip | Dr. Wu Che Yuen Justin |
2005.184 | Effect of High Dose Intravenous and Oral Pantoprazole in Preventioin of Recurrent Bleeding from Peptic Ulcers after Endoscopic Therapy | Prof. Sung J.Y. Joseph |
2005.180 | A Pilot Study of Formula Pinggan in the Treatment of Liver Cirrhosis | Prof. Sung J.Y. Joseph |
2005.166 | A Twelve-week, Randomized, Double-blind, Parallel-group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Atenolol in Patients with Essential Hypertension | Prof. Yu Cheuk Man |
2005.157 | Endoluminal Implantation of Enteryx_ for the Treatment of Gastro-Esophageal Reflux Disease | Prof. Chiu Wai Yan Philip |
2005.156 | Clinical Bioequivalence Study on Two Allopurinol Formulations | Prof. Yin Qiping Ophelia |
2005.155 | Clinical Bioequivalence Study on Two Gliclazide Formulations | Prof. Chow S.S. Mossess |
2005.153 | A double-blind randomized comparison of celecoxib plus esomeprazole versus naproxen plus esomeprazole for prevention of recurrent ulcer bleeding in patients with arthritis and cardiothrombotic diseases (NSAID#8 Study) | Prof. CHAN Francis K. L. |
2005.151 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination with Metformin | Dr. So Wing Yee |
2005.149 | A One-Year, Open-Label, Single Arm, Multi-Center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20mg/kg/day) in Patients Diagnosed with Transfusion-dependent Iron Overload | Dr. Li Chi Kong |
2005.148 | Phase I Study on the Safety and Pharmacokinetics of IMD-1041 in Healthy Male Volunteers | Prof. Brian Tomlinson |
2005.146 | A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese | Prof. Tong Chun Yip Peter |
2005.142 | Phase II Trial of PS-341 in Patients with Hepatocellular Carcinoma | Prof. Mok S.K. Tony |
2005.140 | Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt Gastrointestinal Bleeding of Obscure Origin: A Randomized Study | Prof. Leung W.K. |
2005.139 | A 12-week, Double-Blind, Randomized Study to Investigate the Effect of 500_g Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease | Prof. Hui Shu Cheong David |
2005.138 | International Diabetes Management Practices Study, The | Prof. Chan C.N. Juliana |
2005.137 | Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer | Dr. Ng Chi Fai |
2005.136 | A Single Arm Phase IV Study to Assess Efficacy and Safety of Bevacizumab in Combination With Irinotecan and Infusional 5 | Prof. Chan T.C. Anthony |
2005.133 | Follow-Up Serial Infusions of Natrecor_ (Nesiritide) for the Management of Patients with Heart Failure | Prof. Yu Cheuk Man |
2005.123 | Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen. A Novel Randomized Double-Blind Placebo-Control Clinical Trial in High-Risk Hypertensive Subjects | Prof. Chan Yan Keung Thomas |
2005.121 | Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies | Prof. Brian Tomlinson |
2005.120 | Comparison of Lercanidipine with Nifedipine Slow Release in Essential Hypertension | Prof. Brian Tomlinson |
2005.117 | A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation | Dr. Ng Chi Fai |
2005.115 | Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-aged Men with Metabolic Syndrome | Prof. Kong PS Alice |
2005.114 | A Pilot Study of Enhanced External Counterpulsation for Cerebral Blood Flow Augmentation in Chinese Ischemic Stroke Patients with MCA Stenosis EASY-II | Prof. Wong Ka Sing Lawrence |
2005.111 | Prediction of Blood Pressure Response to Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker by Phenotypic and Genotypic Determinants in Chinese Patients with Type 2 Diabetes, Borderline Hypertension and Microalbuminuria | Prof. Brian Tomlinson |
2005.110 | A Randomized, Double-blind, Two-arms Placebo-controlled, Parallel-group, Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdoninally Obese Patients | Prof. Brian Tomlinson |
2005.109 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies | Dr. Leung WY Nancy |
2005.108 | A Multi-centre, Double-blinded, Randomized, Placebo-Controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome | Prof. Hui David |
2005.103 | Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven_/Niastase_) in Acute Intracerebral Haemorrhage (Trial Phase: 3a) | Prof. Wong Ka Sing Lawrence |
2005.095 | A Randomized, Open-labeled, Parallel, Comparative Study of the Efficacy and Tolerability of Rosuvastatin in LDL-C Reduction Using Different Dosing Regimes of 5mg Daily, 10mg Daily and 10mg Alternate day in Hong Kong Chinese Type 2 Diabetic Patients | Dr. Chow Chun Chung Francis |
2005.093 | A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing with GW679769 (50mg or 150mg) for Three Consecutive Days When Administered with a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects with Known Risk Factors for Post-operative Nausea and Vomiting Who are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated with an Increased Emetogenic Risk | Prof. Gin Tony |
2005.087 | A Comparative Study of Visual Function Using the AcrySof Natural and the Acrysof SA 60 Intraocular Lens (IOLs) | Prof. Lam S.C. Dennis |
2005.084 | Clinical Study to Test the Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients with IBS | Prof. Sung J.Y. Joseph |
2005.068 | A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 | Prof. Lam S.C. Dennis |
2005.067 | Combined Sphincterotomy and ballon dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones - A Randomized Controlled Trial | Dr. Cheung Ka Yin Frances |
2005.063 | A 26 Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing Aliskiren to Ramipril with Optional Addition of Hydrochlorothiazide, Followed by a 4 Week Double-blind, Randomized, Placebo-Controlled Withdrawal in Patients with Essential Hypertension | Prof. Yu Cheuk Man |
2005.058 | A Pilot Study On the Use of A Novel Endoscopic Suturing Device [Eagle Claw_] in Patients with Massive Ulcer Bleeding | Dr. Lau Y.W. James |
2005.051 | Prospective Randomized Study to Determine the Safety, Efficacy and Patients | Dr. Chong K.L. Kelvin |
2005.048 | Treatment with Peginterferon Alfa-2a (40 KD) (PEGASYS_) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment | Prof. Chan Lik Yuen Henry |
2005.044 | Comparison of Lidocaine 2% Gel Versus 1% Amethocaine Eyedrops for Primary Pterygium | Dr. Leung YS Gloria |
2005.035 | Atypical Antipsychotics and Metabolic Outcomes in Chinese Patients: A Comparison of Olanzapine and Risperidone | Dr. Leung Chi Ming |
2005.034 | Evaluation of the Combination Effect of A Bioengineered Skin Substitute and An Oral Aloe Vera for the Treatment of Chronic Diabetic Foot Ulcers in A Prospective, Randomized, Double-Blind Clinical Trial | Prof. Liew Choong Tsek |
2005.028 | A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
2005.022 | A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Safety and Tolerability of Tesaglitazar Therapy in Patients with Type 2 Diabetes and Low HDL-Cholesterol on a Fixed Background Therapy with a Statin | Prof. Kong PS Alice |
Page 245 of 254.